These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 27810704

  • 21. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
    Saito K, Kasai T, Nagura Y, Ito H, Kanazawa M, Fukudo S.
    Gastroenterology; 2005 Nov; 129(5):1533-43. PubMed ID: 16285953
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and structure-activity relationships of pyrazolo[1,5-a]pyridine derivatives: potent and orally active antagonists of corticotropin-releasing factor 1 receptor.
    Takahashi Y, Hibi S, Hoshino Y, Kikuchi K, Shin K, Murata-Tai K, Fujisawa M, Ino M, Shibata H, Yonaga M.
    J Med Chem; 2012 Jun 14; 55(11):5255-69. PubMed ID: 22587443
    [Abstract] [Full Text] [Related]

  • 23. Design, synthesis, and structure-activity relationships of novel pyrazolo[5,1-b]thiazole derivatives as potent and orally active corticotropin-releasing factor 1 receptor antagonists.
    Takahashi Y, Hashizume M, Shin K, Terauchi T, Takeda K, Hibi S, Murata-Tai K, Fujisawa M, Shikata K, Taguchi R, Ino M, Shibata H, Yonaga M.
    J Med Chem; 2012 Oct 11; 55(19):8450-63. PubMed ID: 22971011
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
    Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA.
    Neurogastroenterol Motil; 2005 Jun 11; 17(3):415-22. PubMed ID: 15916629
    [Abstract] [Full Text] [Related]

  • 26. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M, Hongo M, Fukudo S.
    J Gastroenterol Hepatol; 2011 Apr 11; 26 Suppl 3():119-21. PubMed ID: 21443723
    [Abstract] [Full Text] [Related]

  • 27. Corticotropin-releasing factor receptor 1 mediates acute and delayed stress-induced visceral hyperalgesia in maternally separated Long-Evans rats.
    Schwetz I, McRoberts JA, Coutinho SV, Bradesi S, Gale G, Fanselow M, Million M, Ohning G, Taché Y, Plotsky PM, Mayer EA.
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct 11; 289(4):G704-12. PubMed ID: 15994424
    [Abstract] [Full Text] [Related]

  • 28. Translocator protein 18kDa antagonist ameliorates stress-induced stool abnormality and abdominal pain in rodent stress models.
    Kawahara Y, Mitsui K, Niwa T, Morimoto N, Kawaharada S, Katsumata S.
    Neurogastroenterol Motil; 2018 Nov 11; 30(11):e13425. PubMed ID: 30069991
    [Abstract] [Full Text] [Related]

  • 29. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M, Alonso C, Guilarte M, Serra J, Martínez C, González-Castro AM, Lobo B, Antolín M, Andreu AL, García-Arumí E, Casellas M, Saperas E, Malagelada JR, Azpiroz F, Santos J.
    Psychoneuroendocrinology; 2012 Jan 11; 37(1):65-77. PubMed ID: 21641728
    [Abstract] [Full Text] [Related]

  • 30. A balance theory of peripheral corticotropin-releasing factor receptor type 1 and type 2 signaling to induce colonic contractions and visceral hyperalgesia in rats.
    Nozu T, Takakusaki K, Okumura T.
    Endocrinology; 2014 Dec 11; 155(12):4655-64. PubMed ID: 25279793
    [Abstract] [Full Text] [Related]

  • 31. DSP-6952, a novel 5-HT4 receptor partial agonist, inhibits visceral hypersensitivity and ameliorates gastrointestinal dysfunction in experimental animals.
    Mine Y, Itakura T, Oku S, Asada R, Shimizu I.
    Eur J Pharmacol; 2018 May 05; 826():123-132. PubMed ID: 29428470
    [Abstract] [Full Text] [Related]

  • 32. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.
    Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr 05; 292(4):G1037-44. PubMed ID: 17158256
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.
    Miyata K, Ito H, Yamano M, Hidaka K, Kamato T, Nishida A, Yuki H.
    Eur J Pharmacol; 1993 Dec 07; 250(2):303-10. PubMed ID: 8112388
    [Abstract] [Full Text] [Related]

  • 34. Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
    Hirata T, Funatsu T, Keto Y, Akuzawa S, Sasamata M, Miyata K.
    J Pharmacol Sci; 2008 Feb 07; 106(2):264-70. PubMed ID: 18296863
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo.
    Okano S, Nagaya H, Ikeura Y, Natsugari H, Inatomi N.
    J Pharmacol Exp Ther; 2001 Aug 07; 298(2):559-64. PubMed ID: 11454917
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dual role of 5-HT3 receptors in a rat model of delayed stress-induced visceral hyperalgesia.
    Bradesi S, Lao L, McLean PG, Winchester WJ, Lee K, Hicks GA, Mayer EA.
    Pain; 2007 Jul 07; 130(1-2):56-65. PubMed ID: 17161536
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.